• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Maravai Lifesciences Holdings Inc Cl A (NQ: MRVI )

    5.700 -0.080 (-1.38%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Maravai Lifesciences Holdings Inc Cl A

    < Previous 1 2 Next >
    Maravai LifeSciences Announces November 2024 Investor Conference Schedule
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
    From Maravai LifeSciences, Inc.
    Via Business Wire
    Maravai LifeSciences Reports Third Quarter 2024 Financial Results
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
    From TriLink BioTechnologies
    Via Business Wire
    Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
    From TriLink BioTechnologies
    Via Business Wire
    Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Maravai LifeSciences Reports Second Quarter 2024 Financial Results
    Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation 
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Maravai LifeSciences Appoints Trey Martin to Board of Directors
    Maravai announces the appointment of CEO Trey Martin to its Board of Directors, highlighting his leadership, commitment to innovation, and industry experience 
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
    From TriLink BioTechnologies
    Via Business Wire
    Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Maravai LifeSciences Reports First Quarter 2024 Financial Results
    Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation 
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
    From TriLink BioTechnologies
    Via Business Wire
    TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
    From TriLink BioTechnologies
    Via Business Wire
    Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
    Via AB Newswire
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Maravai LifeSciences Announces March 2024 Investor Conference Schedule
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
    Via AB Newswire
    Exposures Product Safety
    Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
    Via AB Newswire
    Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
    Via AB Newswire
    Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
    Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation 
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
    From TriLink BioTechnologies
    Via Business Wire
    Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS
    Via AB Newswire
    Biopharmaceutical Advancements: Dyadic (Nasdaq: DYAI) Raises Industry Standards with Maravai LifeSciences’ (Nasdaq: MRVI) Cygnus Technologies
    Via AB Newswire
    Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
    From Dyadic International, Inc.
    Via GlobeNewswire
    Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Maravai LifeSciences Announces November 2023 Investor Conference Schedule
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    Maravai LifeSciences Reports Third Quarter 2023 Financial Results
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.